Preclinical Study of a Combination of Erlotinib and Bevacizumab in Early Stages of Unselected Non-Small Cell Lung Cancer Patient-Derived Xenografts
Crossref DOI link: https://doi.org/10.1007/s11523-015-0415-4
Published Online: 2016-01-28
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rolff, J.
Becker, M.
Merk, J.
Hoffmann, J.
Fichtner, I.
Text and Data Mining valid from 2016-01-28